Tae Hyun Hwang

Company: Mayo Clinic

Job title: Endowed Chair

Seminars:

Sequential Single Cell Transcriptional & Protein Marker Profiling Reveals TIGIT as a Marker & Therapeutic Target to Enhance CD19 CAR-T Cell Therapy in Patients with Non-Hodgkin’s Lymphoma 3:30 pm

• Exploring the role of TIGIT in CAR-T cells • Investigating TIGIT and CD19 CAR-T cell combinatory therapyRead more

day: Day One

Harnessing Spatial Approaches to Reveal TIGIT/PVR Axis & Improve Anti-PD1 Treatment in Gastrointestinal Cancer 12:30 pm

• Using spatial analysis to identify the role of TIGIT/PVR within the tumor immune microenvironment • Defining a combination strategy of TIGIT/PVR with PD-1/PD-L1 blockadeRead more

day: Day One